The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janas, M. L.
Right arrow Articles by Tarlinton, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janas, M. L.
Right arrow Articles by Tarlinton, D.
The Journal of Immunology, 1999, 163: 4192-4198.
Copyright © 1999 by The American Association of Immunologists

Genetic Evidence for Lyn as a Negative Regulator of IL-4 Signaling1

Michelle L. Janas*, Philip Hodgkin{dagger},{ddagger}, Margaret Hibbs§ and David Tarlinton2,*

* The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne, Victoria, Australia; {dagger} The Centenary Institute of Cancer Medicine and Cell Biology, Newtown, New South Wales, Australia, {ddagger} Medical Foundation, University of Sydney, Sydney, Australia; and § The Ludwig Institute of Cancer Research, Royal Melbourne Hospital, Victoria, Australia

IL-4 has multiple effects on B lymphocytes, many of which are concentration dependent. This is particularly so for Ig isotype switching, where different thresholds of IL-4 stimulation are needed to induce switching from IgM to either IgG1 or IgE. In this report we describe a critical role for the tyrosine kinase Lyn in setting IL-4 signaling thresholds in mouse B lymphocytes. Upon CD40 ligand stimulation of lyn-/- B cells, 10-fold less IL-4 was required to induce switching from IgM to IgG1 and IgE and an increased proportion of B cells isotype switched at each IL-4 concentration. These in vitro results correlate with the in vivo findings that in lyn-/- mice, IgG1 Ab-forming cells develop prematurely in ontogeny and that adult lyn-/- mice have an abnormally high proportion of IgG1-expressing B cells in their spleens. Adult lyn-/- mice also have significantly higher levels of IgE in their serum. These results identify Lyn as a molecule involved in modulating the IL-4 signal in B cells and provide insights into its regulation and how a B cell signaling imbalance may contribute to atopy.




This article has been cited by other articles:


Home page
BloodHome page
V. Parravicini, A.-C. Field, P. D. Tomlinson, M. Albert Basson, and R. Zamoyska
Itch-/-{alpha}{beta} and {gamma}{delta} T cells independently contribute to autoimmunity in Itchy mice
Blood, April 15, 2008; 111(8): 4273 - 7282.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Guo, D. Blair, T. C. Chiles, C. A. Lowell, and T. L. Rothstein
Cutting Edge: B Cell Receptor (BCR) Cross-Talk: The IL-4-Induced Alternate Pathway for BCR Signaling Operates in Parallel with the Classical Pathway, Is Sensitive to Rottlerin, and Depends on Lyn
J. Immunol., April 15, 2007; 178(8): 4726 - 4730.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kitaura, Y. Kawakami, M. Maeda-Yamamoto, V. Horejsi, and T. Kawakami
Dysregulation of Src Family Kinases in Mast Cells from Epilepsy-Resistant ASK versus Epilepsy-Prone EL Mice
J. Immunol., January 1, 2007; 178(1): 455 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-L. Chu and C. A. Lowell
The Lyn Tyrosine Kinase Differentially Regulates Dendritic Cell Generation and Maturation
J. Immunol., September 1, 2005; 175(5): 2880 - 2889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. E. Beavitt, K. W. Harder, J. M. Kemp, J. Jones, C. Quilici, F. Casagranda, E. Lam, D. Turner, S. Brennan, P. D. Sly, et al.
Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity
J. Immunol., August 1, 2005; 175(3): 1867 - 1875.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. W. Harder, C. Quilici, E. Naik, M. Inglese, N. Kountouri, A. Turner, K. Zlatic, D. M. Tarlinton, and M. L. Hibbs
Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1
Blood, December 15, 2004; 104(13): 3901 - 3910.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Odom, G. Gomez, M. Kovarova, Y. Furumoto, J. J. Ryan, H. V. Wright, C. Gonzalez-Espinosa, M. L. Hibbs, K. W. Harder, and J. Rivera
Negative Regulation of Immunoglobulin E-dependent Allergic Responses by Lyn Kinase
J. Exp. Med., June 7, 2004; 199(11): 1491 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. L. Hibbs, K. W. Harder, J. Armes, N. Kountouri, C. Quilici, F. Casagranda, A. R. Dunn, and D. M. Tarlinton
Sustained Activation of Lyn Tyrosine Kinase In Vivo Leads to Autoimmunity
J. Exp. Med., December 16, 2002; 196(12): 1593 - 1604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xu, S.-J. E. Beavitt, K. W. Harder, M. L. Hibbs, and D. M. Tarlinton
The Activation and Subsequent Regulatory Roles of Lyn and CD19 After B Cell Receptor Ligation are Independent
J. Immunol., December 15, 2002; 169(12): 6910 - 6918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Croker, D. M. Tarlinton, L. A. Cluse, A. J. Tuxen, A. Light, F.-C. Yang, D. A. Williams, and A. W. Roberts
The Rac2 Guanosine Triphosphatase Regulates B Lymphocyte Antigen Receptor Responses and Chemotaxis and Is Required for Establishment of B-1a and Marginal Zone B Lymphocytes
J. Immunol., April 1, 2002; 168(7): 3376 - 3386.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. O'Laughlin-Bunner, N. Radosevic, M. L. Taylor, Shivakrupa, C. DeBerry, D. D. Metcalfe, M. Zhou, C. Lowell, and D. Linnekin
Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells
Blood, July 15, 2001; 98(2): 343 - 350.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.